Literature DB >> 30943409

PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.

Eneda Toska1, Pau Castel2, Sagar Chhangawala3, Amaia Arruabarrena-Aristorena4, Carmen Chan4, Vasilis C Hristidis4, Emiliano Cocco4, Mirna Sallaku4, Guotai Xu4, Jane Park5, Gerard Minuesa6, Sophie G Shifman4, Nicholas D Socci7, Richard Koche5, Christina S Leslie3, Maurizio Scaltriti8, José Baselga9.   

Abstract

The PI3K pathway integrates extracellular stimuli to phosphorylate effectors such as AKT and serum-and-glucocorticoid-regulated kinase (SGK1). We have previously reported that the PI3K pathway regulates estrogen receptor (ER)-dependent transcription in breast cancer through the phosphorylation of the lysine methyltransferase KMT2D by AKT. Here, we show that PI3Kα inhibition, via a negative-feedback loop, activates SGK1 to promote chromatin-based regulation of ER-dependent transcription. PI3K/AKT inhibitors activate ER, which promotes SGK1 transcription through direct binding to its promoter. Elevated SGK1, in turn, phosphorylates KMT2D, suppressing its function, leading to a loss of methylation of lysine 4 on histone H3 (H3K4) and a repressive chromatin state at ER loci to attenuate ER activity. Thus, SGK1 regulates the chromatin landscape and ER-dependent transcription via the direct phosphorylation of KMT2D. These findings reveal an ER-SGK1-KMT2D signaling circuit aimed to attenuate ER response through a role for SGK1 to program chromatin and ER transcriptional output.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; KMT2D; PI3K inhibitors; PI3K pathway; SGK1; breast cancer; chromatin regulation; estrogen receptor

Mesh:

Substances:

Year:  2019        PMID: 30943409      PMCID: PMC6503687          DOI: 10.1016/j.celrep.2019.02.111

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  28 in total

1.  FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.

Authors:  Rizwan Saffie; Nan Zhou; Delphine Rolland; Özlem Önder; Venkatesha Basrur; Sydney Campbell; Kathryn E Wellen; Kojo S J Elenitoba-Johnson; Brian C Capell; Luca Busino
Journal:  Cancer Res       Date:  2020-04-29       Impact factor: 12.701

Review 2.  COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.

Authors:  Richard J Fagan; Andrew K Dingwall
Journal:  Cancer Lett       Date:  2019-05-22       Impact factor: 8.679

3.  FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.

Authors:  Amaia Arruabarrena-Aristorena; Jesper L V Maag; Srushti Kittane; Yanyan Cai; Wouter R Karthaus; Erik Ladewig; Jane Park; Srinivasaraghavan Kannan; Lorenzo Ferrando; Emiliano Cocco; Sik Y Ho; Daisylyn S Tan; Mirna Sallaku; Fan Wu; Barbara Acevedo; Pier Selenica; Dara S Ross; Matthew Witkin; Charles L Sawyers; Jorge S Reis-Filho; Chandra S Verma; Ralf Jauch; Richard Koche; José Baselga; Pedram Razavi; Eneda Toska; Maurizio Scaltriti
Journal:  Cancer Cell       Date:  2020-09-03       Impact factor: 31.743

Review 4.  AR-dependent phosphorylation and phospho-proteome targets in prostate cancer.

Authors:  Varadha Balaji Venkadakrishnan; Salma Ben-Salem; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

5.  ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.

Authors:  Guotai Xu; Sagar Chhangawala; Emiliano Cocco; Pedram Razavi; Yanyan Cai; Jordan E Otto; Lorenzo Ferrando; Pier Selenica; Erik Ladewig; Carmen Chan; Arnaud Da Cruz Paula; Matthew Witkin; Yuanming Cheng; Jane Park; Cristian Serna-Tamayo; HuiYong Zhao; Fan Wu; Mirna Sallaku; Xuan Qu; Alison Zhao; Clayton K Collings; Andrew R D'Avino; Komal Jhaveri; Richard Koche; Ross L Levine; Jorge S Reis-Filho; Cigall Kadoch; Maurizio Scaltriti; Christina S Leslie; José Baselga; Eneda Toska
Journal:  Nat Genet       Date:  2020-01-13       Impact factor: 38.330

Review 6.  Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.

Authors:  Henriett Butz; Attila Patócs
Journal:  Cancer Metastasis Rev       Date:  2022-06-27       Impact factor: 9.264

7.  The role of epithelial progesterone receptor isoforms in embryo implantation.

Authors:  Rong Li; Xiaoqiu Wang; Zhenyao Huang; Jayani Balaji; Tae Hoon Kim; Tianyuan Wang; Lecong Zhou; Ashley Deleon; Molly E Cook; Margeaux W Marbrey; San-Pin Wu; Jae Wook Jeong; Ripla Arora; Francesco J DeMayo
Journal:  iScience       Date:  2021-11-20

8.  José Baselga M.D., Ph.D. (1959-2021) leading cancer researcher and oncologist.

Authors:  Moshe Elkabets; Giovanni Blandino
Journal:  J Exp Clin Cancer Res       Date:  2021-05-07

9.  Prohibitin depletion extends lifespan of a TORC2/SGK-1 mutant through autophagy and the mitochondrial UPR.

Authors:  Patricia de la Cruz-Ruiz; Blanca Hernando-Rodríguez; Mercedes M Pérez-Jiménez; María Jesús Rodríguez-Palero; Manuel D Martínez-Bueno; Antoni Pla; Roxani Gatsi; Marta Artal-Sanz
Journal:  Aging Cell       Date:  2021-05-03       Impact factor: 9.304

10.  Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.

Authors:  Tasneem Khanam; Sarah Sandmann; Jochen Seggewiss; Charlotte Ruether; Martin Zimmermann; Allison B Norvil; Christoph Bartenhagen; Gerrit Randau; Stephanie Mueller; Heidi Herbrueggen; Per Hoffmann; Stefan Herms; Lanying Wei; Marius Woeste; Christian Wuensch; Humaira Gowher; Ilske Oschlies; Wolfram Klapper; Wilhelm Woessmann; Martin Dugas; Birgit Burkhardt
Journal:  Blood       Date:  2021-04-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.